Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Integrating Traditional Wisdom With Modern Science: Ginsenosides as Antiheart Failure Agents
Li Zhou1, Yanhua Li1, Wenjie Yin1
1Department of Pharmacy, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China.
Ginseng compounds show promise for treating heart failure (HF) by protecting the heart through multiple mechanisms. Further clinical trials are needed to confirm the efficacy of these natural compounds for HF management.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Traditional Chinese Medicine
Background:
- Heart failure (HF) is a critical global health issue with high mortality.
- Current HF treatments have limitations, necessitating novel therapeutic strategies.
- Ginseng, a traditional medicine, contains ginsenosides with potential cardioprotective properties.
Purpose of the Study:
- To review the mechanisms by which ginsenosides ameliorate heart failure.
- To evaluate the therapeutic potential of ginsenosides and their formulations for HF.
- To identify future research directions for ginsenoside-based HF therapies.
Main Methods:
- Systematic review of preclinical and clinical studies on ginsenosides and HF.
- Analysis of ginsenoside mechanisms, including effects on myocardial metabolism, oxidative stress, inflammation, fibrosis, and apoptosis.
- Evaluation of combined therapies and formulations containing ginsenosides.
Main Results:
- Ginsenosides demonstrate multitarget cardioprotective effects.
- Mechanisms include improved myocardial energy metabolism, reduced oxidative stress and inflammation, attenuated fibrosis, and inhibited cardiomyocyte apoptosis.
- Ginsenoside formulations show synergistic efficacy in preclinical HF models.
Conclusions:
- Ginsenosides are pleiotropic natural compounds with significant therapeutic potential for heart failure.
- Preclinical evidence strongly supports their use, but clinical data is limited.
- Future research should focus on high-quality clinical trials, optimized delivery, and combination therapies for clinical translation.
More Related Videos
09:53Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Heart Failure Drugs: β-Blockers
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology